Literature DB >> 27055870

Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013.

A G Dinmohamed1,2,3, M Brink1, O Visser4, M Jongen-Lavrencic3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27055870     DOI： 10.1038/leu.2016.68

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.

Authors:  T Marchand; T Lamy; H Finel; W Arcese; S Choquet; J Finke; A Huynh; G Irrera; D Karakasis; J Konopacki; J Lambert; M Michieli; H C Schouten; W Schroyens; G Sucak; J Tischer; E Vandenberghe; P Dreger
Journal:  Leukemia       Date:  2015-09-22       Impact factor: 11.528

2.  The relative survival rate.

Authors:  D E Henson; L A Ries
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

3.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

4.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

5.  Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.

Authors:  Benoît Bareau; Jérôme Rey; Mohamed Hamidou; Jean Donadieu; Jeff Morcet; Oumedaly Reman; Nicolas Schleinitz; Olivier Tournilhac; Mikael Roussel; Thierry Fest; Thierry Lamy
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

Review 6.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

7.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

8.  Completeness of cancer registration in Limburg, The Netherlands.

Authors:  L J Schouten; P Höppener; P A van den Brandt; J A Knottnerus; J J Jager
Journal:  Int J Epidemiol       Date:  1993-06       Impact factor: 7.196
  8 in total
  7 in total

Review 1.  Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Authors:  Tal Gazitt; Thomas P Loughran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia.

Authors:  Tyler G Ketterl; David Wu; Jonathan R Fromm; Lorinda Soma; Ann E Dahlberg; Brent L Wood; Katherine Tarlock
Journal:  Bone Marrow Transplant       Date:  2017-12-21       Impact factor: 5.483

Review 3.  Large granular lymphocytic leukemia: a brief review.

Authors:  Ekta Rahul; Aparna Ningombam; Shreyam Acharya; Pranay Tanwar; Amar Ranjan; Anita Chopra
Journal:  Am J Blood Res       Date:  2022-02-15

Review 4.  Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.

Authors:  Katharine B Moosic; Kusuma Ananth; Felipe Andrade; David J Feith; Erika Darrah; Thomas P Loughran
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

Review 5.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

6.  Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.

Authors:  Lisa Pleyer; Hartmut Döhner; Hervé Dombret; John F Seymour; Andre C Schuh; C L Beach; Arlene S Swern; Sonja Burgstaller; Reinhard Stauder; Michael Girschikofsky; Heinz Sill; Konstantin Schlick; Josef Thaler; Britta Halter; Sigrid Machherndl Spandl; Armin Zebisch; Angelika Pichler; Michael Pfeilstöcker; Eva M Autzinger; Alois Lang; Klaus Geissler; Daniela Voskova; Wolfgang R Sperr; Sabine Hojas; Inga M Rogulj; Johannes Andel; Richard Greil
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

Review 7.  Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.

Authors:  Giulia Calabretto; Antonella Teramo; Gregorio Barilà; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Gianpietro Semenzato; Renato Zambello
Journal:  Cells       Date:  2021-10-19       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.